PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Taro leaf and corm extracts demonstrated anti-tumor activity against gastric adenocarcinoma cells in vitro [PMID:38203419].
Taro leaves are reported to have anticancer, antidiabetic, and anti-inflammatory activity due to high bioactive compound content [PMID:35176712].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 37324900 (2023) — Functional profile and encapsulating properties of Colocasia esculenta (Taro). · Food science & nutrition
- 2.PMID: 12730067 (2003) — Tuber storage proteins. · Annals of botany
- 3.PMID: 35176712 (2022) — Nutritional, phytochemical composition and potential health benefits of taro (Colocasia esculenta L.) leaves: A review. · Food chemistry
- 4.PMID: 38203419 (2023) — Activity of Colocasia esculenta (Taro) Corms against Gastric Adenocarcinoma Cells: Chemical Study and Molecular Characterization. · International journal of molecular sciences
- 5.PMID: 41957018 (2026) — Chromosome level genome assembly of taro (Colocasia esculenta).